Adaptive Biotechnologies Corp ADPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
3.01UNCH (UNCH)
Volume
10,530
Close
3.01quote price arrow up+0.08 (+2.73%)
Volume
1,083,446
52 week range
2.28 - 9.08
Loading...
  • Open2.99
  • Day High3.14
  • Day Low2.95
  • Prev Close2.93
  • 52 Week High9.08
  • 52 Week High Date06/14/23
  • 52 Week Low2.28
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap436.728M
  • Shares Out145.09M
  • 10 Day Average Volume1.68M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-38.57

KEY STATS

  • Open2.99
  • Day High3.14
  • Day Low2.95
  • Prev Close2.93
  • 52 Week High9.08
  • 52 Week High Date06/14/23
  • 52 Week Low2.28
  • 52 Week Low Date04/19/24
  • Market Cap436.728M
  • Shares Out145.09M
  • 10 Day Average Volume1.68M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-38.57

RATIOS/PROFITABILITY

  • EPS (TTM)-1.56
  • P/E (TTM)-1.93
  • Fwd P/E (NTM)-2.32
  • EBITDA (TTM)-179.375M
  • ROE (TTM)-58.31%
  • Revenue (TTM)170.276M
  • Gross Margin (TTM)55.63%
  • Net Margin (TTM)-132.32%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adaptive Biotechnologies Corp

 

Content From Our Affiliates

Profile

MORE
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its proprietary technologies to read the diverse genetic code of a patient’s immune system and understand precisely how the immune system detects and treats disease in that patient. It has business around two main areas:...
Chad Robins
Chairman of the Board, Chief Executive Officer, Co-Founder
Julie Rubinstein
President, Chief Operating Officer
Kyle Piskel
Chief Financial Officer
Address
1165 Eastlake Ave E
Seattle, WA
98109
United States

Top Peers

SYMBOLLASTCHG%CHG
PACB
Pacific Biosciences of California Inc
1.83+0.07+3.98%
AKBA
Akebia Therapeutics Inc
1.37+0.07+5.38%
XERS
Xeris Biopharma Holdings Inc
1.89+0.03+1.61%
STRO
Sutro Biopharma Inc
3.83-0.11-2.79%
TRDA
Entrada Therapeutics Inc
13.16-0.40-2.95%